Blog
Featured post
Truveta Data includes linked closed claims for over 200 million patients
By linking complete clinical data with comprehensive claims records, Truveta advances real-world evidence (RWE) generation that can replace, or complement, clinical trials and registries.
LinkedIn Live: Truveta Research discusses recent maternal heart health study
The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color more than white...
From questions to answers: How Truveta Studio was used to create rapid heart health equity insights in just a few weeks
It’s no secret — yet surprising and tragic — that the United States is one of the most dangerous high-income countries in which to give birth. It’s also unfortunately well known...
Preeclampsia-related heart failure disproportionately impacts Black mothers
Among women with preeclampsia, new Truveta Research findings show that Black women are two times more likely to experience heart failure than white women. Maternal health...
“A passion for transforming patient outcomes” – Truveta joins the Precision Medicine World Conference
Last week, I joined a few of my fellow Truvetans, including our CEO Terry Myerson, pictured above, at the Precision Medicine World Conference in Santa Clara, CA for a few days of...
Cardiac arrest while playing sports: How often does it happen?
On January 2, 2023 during NFL Monday Night Football, Buffalo Bills safety Damar Hamlin collapsed on the football field after an un-noteworthy tackle, shocking and saddening NFL...
Truveta research published in Frontiers in Public Health
In November, Truveta Research shared their findings on racial disparities in treatment and hospitalization during different periods of time of the COVID-19 pandemic. Now, the...
Monitoring RSV: What we saw in rates of RSV hospitalization this year
Intended for a scientific audience, Truveta Research Technical Reports are a new way of looking at the timely, representative, and de-identified data in Truveta Studio. The...
How Truveta supports clinical trial recruitment for rare disease research
The key to any disease study is rich data. We recently met with the CEO of a biotech company that specializes in the development of immunotherapies. He and his team had tried to...
Truveta’s 2022 winter holidays
Our Truvetans really know how to relax, whether they were dashing through the snow with their dogs or resting at a spa in sunny Maui. Check out a few of our favorite photos of...